Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01310218 · ClinicalTrials.gov registry record · Phase 4

Length of Post Operative Dressing After Carpal Tunnel Release

A Phase 4 study, sponsored by UConn Health.

Completed
Registry status
Phase 4
Development phase
96
Enrollment target

NCT01310218: Completed Phase 4 study, sponsored by UConn Health.

NCT01310218 is a Phase 4 study that has completed, run by UConn Health. The registered enrollment target is 96 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01310218, a Phase 4 study, has completed, sponsored by UConn Health.

COMPLETED
Registry status
Phase 4
Development phase
96 participants
Enrollment target

Study Summary

The purpose of the study is to prospectively compare the functional, satisfaction, and wound outcomes of patients treated with one of two accepted methods of postoperative dressing following carpal tunnel release. Hypothesis: There will be no difference between the short term (approximately 2 - 3 days)and longer term (9 to 14 days)bulky dressing groups in terms of outcomes.

Primary Outcome

Symptom and function of Carpal Tunnel Syndrome

Interventions

  • OTHER extended postoperative dressing
  • OTHER short postoperative dressing

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2009-05
Est. Completion 2010-11
Phase Phase 4
UConn Health

178 total trials

What the finished NCT01310218 record still lists

NCT01310218 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 2 interventions - of which extended postoperative dressing is the first listed.

NCT01310218 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01310218 about?

NCT01310218 is a clinical study titled "Length of Post Operative Dressing After Carpal Tunnel Release". The purpose of the study is to prospectively compare the functional, satisfaction, and wound outcomes of patients treated with one of two accepted methods of postoperative dressing following carpal tunnel release. Hypothesis: There will be no difference between the short term (approximately 2 - 3 da...

What is the current status of trial NCT01310218?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2009-05. Estimated completion is 2010-11.

What interventions are being tested in trial NCT01310218?

The interventions under investigation include: extended postoperative dressing (OTHER), short postoperative dressing (OTHER).

Who is sponsoring clinical trial NCT01310218?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01310218's enrollment target sits among peer trials

96 863rd of 2000 higher than 1,132 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01310218, the US trial registry maintained by the National Library of Medicine. NCT01310218 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.